openPR Logo
Press release

Ventilator-associated Pneumonia (VAP) Market likely to experience a steep rise in its growth during the forecast period 2017-2025

11-02-2020 10:08 AM CET | Health & Medicine

Press release from: Transparecny Market Research

Ventilator-associated Pneumonia (VAP) Market

Ventilator-associated Pneumonia (VAP) Market

Ventilator associated pneumonia (VAP) is an intensive care unit (ICU) for acquired infection. This pulmonary infection generally occurs 48 hours after a patient is incubated and has received mechanical ventilation. Incidence of VAP ranges from 6% to 55% and can reach up to 76% in some situations. VAP is a major cause of illness and death. Patients suffering with VAP have increased spans of ICU hospitalization. Moreover, death rate has risen to 20% to 30%. The incidence rate of VAP depends on many factors including reintubation, age & altered consciousness, duration of mechanical ventilation, and supine position. Early and precise diagnosis of VAP is tough and there is an urgent need of an optimal antibiotic treatment. Diagnosis of VAP requires high clinical suspicion in combination with bedside examination, microbiologic analysis of respiratory secretions, and radiographic examination. A composite clinical score named clinical pulmonary infection score (CPIS) is derived by observing these. CPIS is based on six criteria: blood leukocyte count, temperature, oxygenation, volume & purulence of tracheal secretions, semiquantitative culture of tracheal aspirate, and pulmonary radiography. Based on these, the treatment of patients suffering from VAP is planned. Precise treatment of VAP is decided after exact causative bacteria of the disease is detected. On the other hand, when VAP is first is suspected, and if the bacteria causing the infection is specifically not known, then broad-spectrum of antibiotics (empiric therapy) are considered for the treatment, until exact cause of disease (particular bacteria) is determined.

Request Brochure for Report -

The global ventilator-associated pneumonia (VAP) market is anticipated to grow rapidly in the near future. Major factors driving the market are rise in geriatric population, increase in hospital acquired in infections, and global rise in respiratory infections. One of the important elements affecting helping growth of hospital acquired infections is, ICU patients have prevailing underlying factors which relates to immunodeficiency for example glucocorticoid therapy or diabetes mellitus. These elements increase the risk of ventilator associated pneumonia (VAP). Other factors fueling the growth of the global ventilator associated pneumonia (VAP) market are rise in investments in health care, reimbursement policies in developed nations of North America and Europe, and advancements in technologies. However, high cost of overall treatment, side effects related to treatments, and lack of reimbursement policies in emerging countries are likely to restrain the market.

The global ventilator-associated pneumonia (VAP) market has been segmented based on diagnosis, mode of treatment, and end-user. In terms of diagnosis, the market has been segmented into radiological, microbiological, clinical, and others. Based on mode of treatment, the global ventilator-associated pneumonia (VAP) market has been divided into home care, hospital care, and others. In terms of end-user, the VAP market consists of hospitals, clinics, research facilities, and others.

Request for Analysis of COVID19 Impact on Cardiac Arrest Treatment Market –

Geographically the global ventilator-associated pneumonia (VAP) market has been divided into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America leads the global market due to better awareness among people about early diagnosis of diseases and rise in the number of respiratory & related infectious diseases. Favorable reimbursement policies and wide acceptance of advanced technologies are the other factors attributed to North America’s dominance of the global market. Europe is also projected to grow quickly, as top players in the market are cooperating with research institutions & labs to develop new innovative products. The market in Asia Pacific is projected to expand at a high growth rate due to increase in disposable income, unmet needs of the rising population, swiftly evolving health care network, improved reimbursement facilities, and health care awareness.

Pre book Ventilator-associated Pneumonia (VAP) Market Report -<ype=S

Key players in the VAP market are Merck & Co., Inc., Adenium Biotech ApS (Denmark), AstraZeneca, MedImmune, Nabriva Therapeutics AG, and Thermo Fisher Scientific.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ventilator-associated Pneumonia (VAP) Market likely to experience a steep rise in its growth during the forecast period 2017-2025 here

News-ID: 2178190 • Views: 177

More Releases from Transparecny Market Research

Petroleum Jelly Market Export Research Report and Forecast to 2031
Negative Influence of COVID-19 Pandemic on Petroleum Jelly Market The COVID-19 pandemic has affected the petroleum jelly market to a considerable extent. The low demand from end-use industries led to a decline in the growth rate of the petroleum jelly market. Frequent lockdowns due to the emerging variants of the novel coronavirus caused disruptions in the production process. It also led to disturbances in the supply chain mechanisms. This aspect has
Lactic Acid & Polylactic Acid Market Historical Analysis and Industry Outlook 20 …
Reaching Sustainable Goals Delayed Due to COVID-19 Pandemic Although the COVID-19 outbreak has had a short-term positive impact on reducing greenhouse gas (GHG) emissions, it has delayed the timeline for reaching sustainable development goals. The adoption of sustainable production processes is linked to high costs. Such findings are anticipated to affect business activities in the lactic acid & polylactic acid market, since stakeholders are bullish on expanding uses of polylactic acid
Dehydrated Vegetables Market to Witness a Pronounce Growth at CAGR during 2018-2 …
Dehydrated Vegetables Market to Witness a Pronounce Growth at CAGR during 2018-2028 Food or vegetables dehydration or drying is a process that is used to eliminate moisture from food products and vegetables as it helps in preservation for long periods of time. Food dehydration is highly adopted as an ideal process to preserve seasonal fruits and vegetables. With easy storage, high nutritional value, and cost effectiveness, dehydrated vegetables have been witnessing
Succinic Acid Market Product Quality, Competitive Analysis and Opportunity Asses …
Succinic Acid Market: Introduction In terms of value, the global succinic acid market is anticipated to expand at a CAGR of ~7% from 2019 to 2027. Succinic acid is widely used in various industries such as pharmaceuticals, chemical, and food. Currently, major proportion of succinic acid is derived from petroleum feedstock Increase in construction and infrastructure development activity is expected to trigger the demand for resin, coating, and polyurethanes, which in

All 5 Releases

More Releases for VAP

Ventilator Associated Pneumonia (VAP) Market size, Share, Growth & Forecast 2026
Ventilator Associated Pneumonia (VAP) Market Overview: 2026 This report focuses on the global Ventilator Associated Pneumonia (VAP) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Ventilator Associated Pneumonia (VAP) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. Inquire For Sample: The key players covered in this study Philips Respironics Hoffrichter
Expanding Worldwide Market of Ventilator Associated Pneumonia (VAP) Research rep …
The Ventilator Associated Pneumonia (VAP) industry report examines marked growth trends and technological developments that will come to the fore in the said Ventilator Associated Pneumonia (VAP) market in the coming years. In addition, the Ventilator Associated Pneumonia (VAP) market report includes historical growth markers, competitive hierarchy, and development trends and data about how these indices will change in the regional and international markets in the coming years. For a detailed
Germany Ventilator Associated Pneumonia (VAP) Therapeutics Market Status and Out …
A fresh report has been added to the wide database of Market Research Hub (MRH) titled “Germany Ventilator Associated Pneumonia (VAP) Therapeutics Market Research Report 2018” which provides an outlook for current market value as well as the expected forecast including Rate on Investment (ROI) together with growing CAGR of XX% during 2018-2022. This report studies the Ventilator Associated Pneumonia (VAP) Therapeutics development status and future trend in Germany, focuses
Ventilator Associated Pneumonia (VAP) Therapeutics Market 2017- Bayer AG, Achaog …
Apex Market Reports, recently published a detailed market research study focused on the "Ventilator Associated Pneumonia (VAP) Therapeutics Market" across the global, regional and country level. The report provides 360° analysis of "Ventilator Associated Pneumonia (VAP) Therapeutics Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Ventilator Associated Pneumonia (VAP) Therapeutics industry,
Ventilator Associated Pneumonia (VAP) - Pipeline Review, H2 : Pharmaceuticals In …
Market Research Hub's latest Pharmaceutical and Healthcare disease pipeline guide “Ventilator Associated Pneumonia Pipeline Review”, H2 2017, provides an overview of the Ventilator Associated Pneumonia (VAP) (Infectious Disease) pipeline landscape. Ventilator-associated pneumonia (VAP) is pneumonia that develops 48 hours or longer after mechanical ventilation is given by means of an endotracheal tube or tracheostomy. Ventilator-associated pneumonia (VAP) results from the invasion of the lower respiratory tract and lung parenchyma by microorganisms.
Ventilator Associated Pneumonia (VAP) - Pipeline Review, H2 2017
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Ventilator Associated Pneumonia (VAP) - Pipeline Review, H2 2017”. Global Markets Direct's latest Pharmaceutical and Healthcare disease provides an overview of the Ventilator Associated Pneumonia (VAP) (Infectious Disease) pipeline landscape. Request For Sample Report@ Ventilator-associated pneumonia (VAP) is pneumonia that develops 48 hours or longer after mechanical ventilation is given by means of an